Market Segmentation Tab
Vitamin K2 Product Type Outlook (USD Million, 2018-2030)
Vitamin K2 Source Outlook (USD Million, 2018-2030)
Vitamin K2 Application Outlook (USD Million, 2018-2030)
Vitamin K2 Form Outlook (USD Million, 2018-2030)
Vitamin K2 Regional Outlook (USD Million, 2018-2030)
Research Methodology on Vitamin K2 Market
This research report is based on a comprehensive study of the global Vitamin K2 market. To conduct the research, the analysis is mainly based on secondary and primary research techniques. Initially, for the secondary research method, the researchers used effective industry publications such as books and journals, websites, and press releases. This involves the assessment of available statistics from both international and well-established associations, such as associations from the industry and regulatory bodies.
For the determination of market size, primary and secondary research techniques were used. Initially, for the secondary research technique, the researchers gathered information from company press releases, annual reports, websites of the company, and other sources. Furthermore, data is collected from secondary sources using a mix of top-down and bottom-up approaches, while studying various other factors related to the market.
For the primary research technique, primary sources such as surveys, interviews, telephone calls, and face-to-face interviews with industry experts, end-users, vendors, and research participants are adopted by the researchers. Furthermore, these interviews are conducted across various regions, such as North America, which helped develop a clear image of the market.
To understand the factor influencing the Vitamin K2 market, a vigorous market analysis is performed. To generate meaningful insights, Porter’s five force model was used. The researchers also used SWOT analysis to evaluate the information collected from the secondary sources accurately. Moreover, several inputs from industry leaders and their opinions were used to conceptualize and validate the market size. This entire process of data collection and validation resulted in the accurate estimation of the market size.
Further, the researchers studied each section and sub-section related to the market. This includes the highest revenue-generating sources, leading product categories and segments, and market trends. Through secondary sources, secondary data is evaluated and clarified, while graphs and tables helped the researchers to explain the data properly.
Apart from this, market drivers, restraints, and trends were studied and their impact on the estimated market size was calculated. To what extent the market demand is met by various stakeholders is also quantified and explored. To measure the market share of each player in terms of market value, market segmentation was used. Additionally, the attractiveness of various market segments is calculated using the attractiveness index. In addition, market forecasts and estimates were made based on qualitative and quantitative research.
The market prediction discussed in the report is based on aspects such as past and current market analysis, political trends, demographic trends, and economic trends. To analyze the market environment, the study focused on government policies, initiatives, and regulations that would strengthen the market position. The research also considered the presence of potential barriers in the form of competition and its impact on market growth.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PATIENT POOL SUFFERING FROM VITAMIN DEFICIENCY
4.2.2 GROWING DEMAND FOR NUTRACEUTICAL PRODUCTS CONTAINING VITAMIN K2
4.2.3 RISING CASES OF OSTEOPOROSIS AND ARTHRITIS
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATIONS FOR NUTRACEUTICALS
4.4 OPPORTUNITY
4.4.1 MULTIFUNCTIONAL INGREDIENTS
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
5.2.1 RAW MATERIAL PLANNING & PROCUREMENT
5.2.1.1 FERMENTATION
5.2.1.2 FILTRATION
5.2.1.3 EXTRACTION
5.2.1.4 FILTRATION PURIFICATION
5.2.2 PACKAGING
5.2.3 TRANSPORTATION
5.2.4 DISTRIBUTION MARKETING & SALES
5.2.5 POST-SALES SERVICES
5.3 COVID-19 IMPACT ANALYSIS
5.3.1 IMPACT ON R&D
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON RAW MATERIAL
5.3.4 IMPACT ON DEMAND
6 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 MK-7
6.3 MK-4
6.4 COMBINATION DRUGS
7 GLOBAL VITAMIN K2 MARKET, BY SOURCE
7.1 OVERVIEW
7.2 NATURAL
7.3 SYNTHETIC
8 GLOBAL VITAMIN K2 MARKET, BY FORM
8.1 OVERVIEW
8.2 CAPSULE & TABLETS
8.3 POWDER
8.4 OILS
8.5 OTHERS
9 GLOBAL VITAMIN K2 MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 NUTRACEUTICAL AND FOOD
9.3 PHARMACEUTICAL
10 GLOBAL VITAMIN K2 MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 SOUTH AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE VITAMIN K2 MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE VITAMIN K2 MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 PARTNERSHIP/ ACQUISITION
11.6.3 PRODUCT PROMOTION/EXPANSION
11.7 FINANCIAL MATRIX
11.7.1 SALES, 2020
11.7.2 R&D EXPENDITURE
12 COMPANY PROFILES
12.1 KAPPA INGREDIENTS GMBH
12.1.1 COMPANY OVERVIEWS
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 LESAFFRE & CIE
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
This is a privately held company. Hence, the financial information is not available in the public domain.
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 VIRIDIS BIOPHARMA PVT. LTD.
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 SEEBIO BIOTECH (SHANGHAI) CO., LTD.
12.4.1 COMPANY OVERVIEWS
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 DSM
12.5.1 COMPANY OVERVIEWS
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 INTERNATIONAL FLAVORS & FRAGRANCES INC.
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 KYOWA HAKKO BIO CO. LTD.
12.7.1 COMPANY OVERVIEWS
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 PURAYATI
12.8.1 COMPANY OVERVIEWS
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 VOX NUTRITION INC.
12.9.1 COMPANY OVERVIEWS
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 ANDERSON GLOBAL GROUP, LLC
12.10.1 COMPANY OVERVIEWS
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL VITAMIN K2 MARKET FOR MK-7, BY REGION, 2018-2027 (USD MILLION)
TABLE 5 GLOBAL VITAMIN K2 MARKET FOR MK-4, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 GLOBAL VITAMIN K2 MARKET FOR COMBINATION DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 8 GLOBAL VITAMIN K2 MARKET, FOR NATURAL, BY REGION 2018-2027 (USD MILLION)
TABLE 9 GLOBAL VITAMIN K2 MARKET, FOR SYNTHETIC, BY REGION 2018-2027 (USD MILLION)
TABLE 10 GLOBAL VITAMIN K2 MARKET, BY FORM, 2018-2027, (USD MILLION)
TABLE 11 GLOBAL VITAMIN K2 MARKET FOR CAPSULE & TABLETS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 GLOBAL VITAMIN K2 MARKET FOR POWDER, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 GLOBAL VITAMIN K2 MARKET FOR OILS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14 GLOBAL VITAMIN K2 MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 16 GLOBAL VITAMIN K2 MARKET FOR NUTRACEUTICAL AND FOOD, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 GLOBAL VITAMIN K2 MARKET FOR PHARMACEUTICAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 GLOBAL: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 19 AMERICAS: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 20 AMERICAS: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 21 AMERICAS: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 22 AMERICAS: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 23 AMERICAS: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 24 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 25 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 26 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 27 NORTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 29 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 30 US: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 31 US: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 32 US: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 33 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 34 CANADA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 35 CANADA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 36 CANADA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 37 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 38 SOUTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 39 SOUTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 40 SOUTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 41 EUROPE: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 42 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 43 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 44 EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 45 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 46 WESTERN EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 47 WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 48 WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 49 WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 50 WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 51 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 52 GERMANY: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 53 GERMANY: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 54 GERMANY: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 55 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 56 FRANCE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 57 FRANCE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 58 FRANCE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 59 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 60 UK: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 61 UK: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 62 UK: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 63 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 64 ITALY: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 65 ITALY: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 66 ITALY: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 67 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 68 SPAIN: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 69 SPAIN: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 70 SPAIN: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 71 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 72 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 73 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 74 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 75 EASTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 76 EASTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 77 EASTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 78 EASTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 79 ASIA-PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 80 ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 81 ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 82 ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 83 ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 84 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 85 CHINA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 86 CHINA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 87 CHINA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 88 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 89 JAPAN: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 90 JAPAN: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 91 JAPAN: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 92 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 93 INDIA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 94 INDIA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 95 INDIA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 96 AUSTRALIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 97 AUSTRALIA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 98 AUSTRALIA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 99 AUSTRALIA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 100 SOUTH KOREA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 101 SOUTH KOREA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 102 SOUTH KOREA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 103 SOUTH KOREA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 104 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 105 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 106 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 107 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 108 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 113 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 114 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 115 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 116 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 117 AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
TABLE 118 AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)
TABLE 119 AFRICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)
TABLE 120 AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)
TABLE 121 MAJOR MANUFACTURERS IN THE VITAMIN K2 MARKET
TABLE 122 MOST ACTIVE PLAYER IN THE VITAMIN K2 MARKET
TABLE 123 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 124 PARTNERSHIP/ ACQUISITION
TABLE 125 PRODUCT PROMOTION/EXPANSION
TABLE 126 KAPPA INGREDIENTS GMBH: PRODUCTS/SERVICES OFFERED
TABLE 127 KAPPA INGREDIENTS GMBH: KEY DEVELOPMENTS
TABLE 128 LESAFFRE: PRODUCTS/SERVICES OFFERED
TABLE 129 LESAFFRE: KEY DEVELOPMENTS
TABLE 130 VIRIDIS BIOPHARMA PVT. LTD. : PRODUCTS/SERVICES OFFERED
TABLE 131 SEEBIO BIOTECH (SHANGHAI) CO., LTD: PRODUCTS/SERVICES OFFERED
TABLE 132 DSM: PRODUCTS/SERVICES OFFERED
TABLE 133 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SERVICES OFFERED
TABLE 134 INTERNATIONAL FLAVORS & FRAGRANCES INC.: KEY DEVELOPMENTS
TABLE 135 KYOWA HAKKO BIO CO.: PRODUCTS/SERVICES OFFERED
TABLE 136 PURAYATI.: PRODUCTS/SERVICES OFFERED
TABLE 137 VOX NUTRITION INC.: PRODUCTS/SERVICES OFFERED
TABLE 138 ANDERSON GLOBAL GROUP, LLC.: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 4 SUPPLY CHAIN ANALYSIS: GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 5 PORTER’S FIVE FORCES MODEL
FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2019 & 2027 (USD MILLION)
FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION)
FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2019 & 2027 (USD MILLION)
FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 10 AMERICAS: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 11 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 12 EUROPE: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 13 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 14 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 15 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 16 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 17 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 18 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 20 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MERCK KGAA: SWOT ANALYSIS
FIGURE 22 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 24 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 26 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 28 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 30 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 BIOMÉRIEUX SA: SWOT ANALYSIS
FIGURE 32 LONZA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 LONZA: SWOT ANALYSIS
FIGURE 34 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW
FIGURE 35 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 36 HIMEDIA LABORATORIES: SWOT ANALYSIS
FIGURE 37 CORNING INCORPORATED: FINANCIAL OVERVIEW
FIGURE 38 ORNING INCORPORATED: SWOT ANALYSIS
FIGURE 39 PROMOCELL: SWOT ANALYSIS
FIGURE 40 THE SARTORIUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 THE SARTORIUS GROUP: SWOT ANALYSIS
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
